Toronto, Canada / February 27th, 2014 / ACCESSWIRE / Open Source Health Inc. (CSE:OSH) ( the "Company"), a digital integrated healthcare company dedicated to advancing life-long solutions for women's health and wellness, advises that it is changing its financial year end from December 31st to September 30th, in accordance with the requirements of National Instrument 51-102 Continuous Disclosure Obligations.
The change in financial year end from December 31 to September 30 will allow the Company to provide continuous disclosure information on a comparable basis with its industry peer group.
As a result of the change, the Company will have a 12 month transition year ending September 30, 2014. Further details regarding the change in financial year, including the Company's interim reporting periods, will be available in the Company's Notice of Change of Financial Year-End prepared in accordance with section 4.8 of NI 51-102, which will be filed shortly on SEDAR at www.sedar.com.
About Open Source Health:
Open Source Health takes a truly patient-centered approach and is in the business of providing a real-time integrative healthcare solution for women in an open source architecture. Open Source Health is set to lead the current healthcare revolution by capitalizing on the latest trends in: digital health, personalized health, social health, mobile health, and participatory medicine.
For more information, visit www.opensourcehealth.com
Contact:
For further information, please contact Investor Relations at Open Source Health Inc.
Toll Free: 1.866.403.1933
[email protected]
Forward Looking Statements
Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of OSH, including, but not limited to, the impact of general economic conditions, industry conditions, dependence upon regulatory and shareholder approvals, the execution of definitive documentation and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.
THIS PRESS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO SELL ANY OF THE SECURITIES DESCRIBED HEREIN IN THE UNITED STATES. THESE SECURITIES HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.